Skip Navigation

European Heart Journal 2001 22(2):174-180; doi:10.1053/euhj.2000.2126
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wiegand, U.K.H
Right arrow Articles by Katus, H.A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiegand, U.K.H
Right arrow Articles by Katus, H.A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?

U.K.H Wieganda,f1, J Potratza, F Bodea, R Schreiberb, H Bonnemeiera, W Petersa and H.A Katusa

a Medical University of Lübeck, Department of Internal Medicine II, Lübeck, Germany
b Department of Finances, Lübeck, Germany

revised January 10, 2000; accepted January 14, 2000

Abstract

Aims Implantation of single-lead VDD pacemakers is an established alternative to DDD pacing in patients with atrioventricular block. This study compares the long-term costs of both systems.

Methods and Results Three hundred and sixty patients with atrioventricular block received VDD or DDD pacemakers in alternating order. Primary costs of implantation included: devices, leads and operation material, surgeons, nurses, medical technicians, and hospitalization. The mean cost of an uncomplicated DDD pacemaker implantation was defined as 1000 virtual cost-units (CU). Costs of pacemaker related complications or re-operations as well as upgrades from VDD to DDD devices were considered secondary costs and assessed during a mean follow-up period of 42±15 months. Pacing efficacy was assessed by event-free survival with maintained atrioventricular synchronized pacing mode. Costs of pacemaker devices were not different (639±26CU in VDD vs 641±32CU in DDD, ns). However, due to lower costs of lead hardware (102±10CU in VDD vs 133±14CU in DDD, P<0·001) and shorter implantation procedures (44·3±5·1min vs 74·4±13·5min, P<0·001), costs of an uncomplicated implantation were 8·9% lower in the VDD group (911±35CU vs 1000±39CU,P <0·001). A smaller complication rate in the VDD group led to a 16·1% reduction of secondary costs (26±17CUyear–1vs 31± 25CUyear–1,P =0·024). Event-free survival did not differ between groups (83·4% in VDD vs 84·9% in DDD, ns).

Conclusion Use of single-lead VDD pacemakers achieves significant reduction of implantation and follow-up costs without loss of therapeutic efficacy compared to conventional DDD systems.

Key Words: Cost-effectiveness, dual-chamber pacing, single-lead VDD pacing, complications

f1 Correspondence: Dr med. Uwe K. H. Wiegand, Medizinische Universität zu Lübeck, Medizinische Klinik II, Ratzeburger Allee 16013538 Lübeck, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Card Surg AdultHome page
H. M. Spotnitz
Surgical Implantation of Pacemakers and Automatic Defibrillators
Card. Surg. Adult, January 1, 2008; 3(2008): 1395 - 1428.
[Full Text]


Home page
EuropaceHome page
M. Kuhne, B. Schaer, C. Kaufmann, N. Moulay, T. Cron, T. Cueni, P. Weiss, C. Schindler, C. Sticherling, and S. Osswald
A randomized trial comparing two different approaches of pacemaker selection
Europace, December 1, 2007; 9(12): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]


Home page
EuropaceHome page
I. Zupan, L. Lipar, D. Zizek, W. Boute, M. Vidmar, T. Gabrijelcic, P. Rakovec, and A. Brecelj
Retrospective analysis of mode survival, reliability of atrial sensing and incidence of atrial tachyarrhythmias in 307 single-lead VDD pacemaker patients
Europace, October 1, 2006; 8(10): 855 - 858.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Eberhardt, F Bode, H Bonnemeier, F Boguschewski, M Schlei, W Peters, and U K H Wiegand
Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity
Heart, April 1, 2005; 91(4): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Brunner, M. Olschewski, A. Geibel, C. Bode, and M. Zehender
Long-term survival after pacemaker implantation: Prognostic importance of gender and baseline patient characteristics
Eur. Heart J., January 1, 2004; 25(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
H. M. Spotnitz
Pacemakers and Automatic Defibrillators
Card. Surg. Adult, January 1, 2003; 2(2003): 1293 - 1326.
[Full Text]


Home page
EuropaceHome page
S. Pakarinen and L. Toivonen
Pre-implant determinants of adequate long-term function of single lead VDD pacemakers
Europace, January 1, 2002; 4(2): 137 - 141.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.